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Emerging data suggest that several metabolic factors, released mainly by white adipose tis-
sue (WAT) and joint tissues, and collectively named adipokines, might have a role in the
pathophysiology of OA. Recently, novel adipokines such as SERPINE2, WISP2, GPNMB
and ITIH5 have been identified in WAT. The main goal of this study was to analyse the ex-
pression of these novel adipokines in synovium, infrapatellar fat pad and chondrocytes and
to compare the expression of these molecules in healthy and OA tissues.
Methods
Synovial tissues, infrapatellar fat pad and chondrocytes were obtained from 36 OA patients
(age 52–85; mean BMI 28.9) who underwent total knee replacement surgery. Healthy syno-
vial tissues and infrapatellar fat pad were obtained from 15 traumatic knee patients (age
23–53; mean BMI 23.5). mRNA and protein expression were determined by qRT-PCR and
western blot analysis respectively.
Results
All the novel adipokines, matter of our study, are expressed in OA synovium, infrapatellar
fat pad and chondrocytes. Moreover, we detected a differential expression of SERPINE2
and ITIH5 in OA synovial tissues as compared to healthy samples. Finally, we also ob-
served an increased expression of WISP2 in OA infrapatellar fat pad in comparison to
healthy controls.
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Conclusions
In this study we demonstrated for the first time the expression of four novel adipokines in dif-
ferent joint tissues and how these molecules are differentially expressed in healthy and OA
joint tissues.
Introduction
Osteoarthritis (OA) is one of the most common form of arthritis and a major cause of pain and
disability in adult population. Although, OA was first considered a disorder of the articular car-
tilage, nowadays it is generally recognized that OA affects all joint tissues, including synovium,
ligaments, tendons, muscle and subchondral bone [1]. Several risk factors contribute to osteo-
arthritis development, including sex, age, mechanical factors or obesity, among others. Due to
the increased fat mass, obesity enhances mechanical stress in weight bearing joints, but also
contributes to joint tissues degeneration by producing and releasing a plethora of factors called
adipokines [2]. Adipose tissue is currently considered a very active endocrine organ able to se-
crete many factors which could participate in the pathophysiology of OA [2]. Noteworthy,
most of these molecules are produced and secreted also by joint cell populations such as chon-
drocytes and/or synovial fibroblasts [3,4].
Very recently the expression of different genes involved in cell differentiation and turnover
of extracellular matrix have been identified in adipocytes [5,6]. Serpin peptidase inhibitor,
clade E member 2 (SERPINE2); WNT1 inducible signalling pathway protein 2 (WISP2); glyco-
protein (transmebrane) nmb (GPNMB) and inter-alpha-trypsin inhibitor heavy chain family,
member 5 (ITIH5) have been characterized as potential new adipokines [5,6]. All these genes
are up-regulated in obesity [6]. In addition, few functional studies postulated the involvement
of these new adipokines in different obesity-related processes [7,8].
Previously, we have demonstrated that chondrocytes, synovial tissues and infrapatellar fat
pad (IPFP) expressed efficiently several adipokines, most of them with pro-inflammatory fea-
tures [3,9].
Thus, in the present study we aimed to analyze the constitutive expression of these new adi-
pokines (SERPINE2, WISP2, GPNMB and ITIH5) in different joint tissues such as chondro-
cytes, synovium and infrapatellar fat pad. Moreover, we assessed and compared the expression
of these factors in healthy and OA synovial tissues and in the infrapatellar fat pad.
Methods
Patients and samples
This study was conducted with the approval of the Santiago University Clinical Hospital Ethics
Committee, approval Number 2014/310. Participants provide their written informed consent
to participate in this study. Samples were extracted from thirty six OA patients (age 52–85;
mean BMI 28.9) who underwent total knee joint replacement. Fifteen healthy controls (age 23–
53; mean BMI 23.5) with traumatic knee lesions (no clinical history of osteoarthritis diseases)
were also included in the study.
Collection of samples was conducted with the approval of the Santiago University Clinical
Hospital Ethics Committee. Synovial tissues and infrapatellar fat pads were collected, washed
and stored at -80°C. Cartilage samples were used to obtain human primary chondrocytes
cultures.
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Cell culture
Human primary chondrocytes culture was developed as previously described [3]. Briefly,
Human chondrocytes were cultured in DMEM/Ham’s F12 medium supplemented with 10% of
fetal bovine serum, L-glutamine, and antibiotics (50 units/ml penicillin and 50 μg/ml
streptomycin).
RNA isolation and real-time reverse transcription–polymerase chain reaction (RT-qPCR)
mRNA levels were determined using SYBR-green based quantitative PCR (qPCR). Briefly,
mRNA from synovial tissues, infrapatellar fat pad and chondrocytes was extracted using TRI-
zol (Life Technologies, NY, USA) and NucleoSpin kit according to the manufacturer’s instruc-
tions. The mRNA was reverse-transcribed (RT) using a SABiosciences First Strand Kit. After
the RT reaction, qPCR analysis was performed with a SABiosciences Master Mix and specific
PCR primers for: human SERPINE2 (156 bp, PPH08354A, reference position 1101, GenBank
accession no. NM_006216.3); humanWISP2 (123 bp, PPH00981B, reference position 1257,
GenBank accession no. NM_003881.2); human GPNMB (110 bp, PPH18941A, reference posi-
tion 1406, GenBank accession no. NM_002510.2); human ITIH5 (149 bp, PPH14913A, refer-
ence position 1843, GenBank accession no. NM_030569.6); human GAPDH (175 bp,
PPH00150E, reference position 1287, GenBank accession no. NM_002046.3). The data were
calculated, using the comparative (ΔΔCt) method and the MxPro software (Stratagene, CA,
USA), as the ratio of each gene to the expression of the housekeeping gene. Data are shown as
mean ± s.e.m (error bars) of the independent samples and represented as fold-change vs.
controls.
Western blot analysis
Small pieces of frozen tissues were placed into 1.5 mL centrifuge tubes and then homogenized
by using a Turrax homogenizer (IKA, Germany) in lysis buffer for protein extraction (10 mM
Tris/HCl, pH 7.5, 5 mM EDTA, 150 mMNaCl, 30 mM sodium pyrophosphate, 50 mM sodium
fluoride, 1 mM sodium orhtovanadate, 0.5% Triton X-100, 1mM PMSF, protease inhibitor
cocktail). Tissues lysates were obtained by centrifugation at 14.000g for 20 min at 4°C.
Equal amount of protein were subjected to 10% sodium dodecyl sulphate polyacrylamide
gel electrophoresis and transferred to a polyvinylidene difluoride transfer membrane (Immobi-
lon-P transfer membrane, Millipore, MA) using a Trans-Blot semi-dry transfer cell (BioRad,
CA, USA). Blots were incubated with the appropriate antibody (anti-SERPINE2 1:1000, R&D
Systems, MN, USA; anti-ITIH5 1:1000, ABCAM, UK; anti-WISP2 1:1000, Abnova, Taiwan).
Immunoblots were visualized with Immobilon Western Detection kit (Millipore, MA) using
horseradish peroxidase-labeled secondary antibody. To confirm equal loading for each sample,
membranes were incubated with stripping buffer (100 mM β-mercaptoethanol, 2% SDS,
62.5 mM Tris-HCl pH 6.7) and re-blotted with anti-β-actin antibody (Sigma, MO, USA). Im-
ages were captured and analyzed with an EC3 imaging system (UVP, CA, USA).
Agarose gel electrophoresis
Amplicons of the different genes were electrophoresed on 2% agarose gel and stained with
ethidium bromide.
Statistical analysis
Data are reported as mean ± S.E.M. (error bars) of the independent samples. Statistical analyses
were performed by ANOVA followed by unpaired t-test and Student-Newman-Keuls test,
using the GraphPad Prism 4 software, with p values<0.05 considered significant.
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Results
Constitutive expression of SERPINE2, WISP2, GPNMB and ITIH5 in synovium, infrapatellar
fat pad and chondrocytes from OA patients. As shown in Fig 1A, we detected the mRNA ex-
pression of all the adipokines in the OA synovial tissues and in the IPFPs. These genes dis-
played a similar expression pattern in both tissues, being WISP2 the most expressed adipokine
(Fig 1A).
To note, OA chondrocytes also expressed SERPINE2, WISP2, GPNMB and ITIH5 (Fig 1A).
Quantitative expression of SERPINE2, WISP2, GPNMB and ITIH5 mRNAS in the different
tissues are reported in Fig 1B.
Comparison between healthy and OA synovium. As shown in Fig 2A, SERPINE2 mRNA
and protein expression was significantly up-regulated in OA synovial tissues in comparison to
healthy samples. On the other hand, ITIH5 expression was decreased in OA tissues (Fig 2A).
However, we did not observe any variation on WISP2 or GPNMB expression between OA and
healthy synovial tissues (data not shown).
A, B low panels. Determination of SERPINE2, ITIH5 and WISP2 protein expression by
western blot. A representative western blot of five different experiments, using five healthy and
five OA samples was shown. β-actin was used to confirm an equal loading for each sample.
Comparison between healthy and OA infrapatellar fat pad. Among all the analyzed adipo-
kines, we only found differences in the expression of WISP2, which was up-regulated in OA
IPFP compared to healthy IPFP (Fig 2B).
We did not detect any variation on SERPINE2, GPNMB and ITIH5 expression between
healthy and OA samples (data not shown).
Fig 1. SERPINE2, WISP2, GPNMB and ITIH5 expression evaluated by real-time reverse transcription
PCR (qRT-PCR) in synovia, IPFP and chondrocytes obtained fromOA patients. A. Amplicons were
electrophoresed on 2% agarose gel and stained with ethidium bromide. B. Determination of the basal mRNA
expression of SERPINE2, WISP2, GPNMB and ITIH5 in synovial tissues, IPFP and chondrocytes of 30 OA
patients. The results were expressed using the ΔΔCt data analysis method. Statistical analysis was
performed using One-way ANOVA followed by Newman-Keuls Multiple Comparison Test. P value *** =
p<0.001WISP2 vs SERPINE2; GPNMN; ITIH5.
doi:10.1371/journal.pone.0123601.g001
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Discussion
Osteoarthritis is considered a disease of the whole joint, which is characterized by articular car-
tilage degradation, synovial inflammation, ligaments degeneration, but also by bone and mus-
cle alterations [1]. Obesity is considered a relevant risk factor for OA development and
progression, not only for the increased mechanical stress to which obese individuals joints are
subjected. Also altered adipokine´s secretion, most of them with pro-inflammatory features,
due to a dysfunctional adipose tissue contributes to the known chronic low grade inflammatory
status presented in obese people, which in turn could affect joint tissues homeostasis [2]. Previ-
ously, our group and others have demonstrated the presence of several adipose tissue-derived
factors in the OA joint. For instance, leptin and chemerin, positively correlated with the severi-
ty of osteoarthritis [9–11]. Actually, the local production by joint tissues has been postulated as
an important source of these adipokines as well as other inflammatory mediators [9,12–14].
Therefore, the alteration of their secretion pattern during OA could impact cartilage and syno-
vium homeostasis. In fact, IPFPs and synovial fibroblasts, exposed to pro-inflammatory cyto-
kines such as IL-1β, released large amounts of pro-inflammatory mediators, including
prostaglandinE2, TNF-α or IL-6, and adipokines such as leptin [15]. Taken together, all these
observations suggest that IPFP and synovium are highly active tissues within the joint, able to
produce multiple pro-inflammatory factors, which in turn can participate in the initiation and
perpetuation of synovitis and OA symptoms.
Very recently novel molecules have been identified in WAT and they are supposed to be in-
volved in cell differentiation and extracellular matrix homeostasis (SERPINE2, WISP2,
GPNMB and ITIH5) [5,6]. In this study we sought to analyse the expression of these novel fac-
tors in healthy and OA joint tissues, in order to test their potential modulation in OA.
First, we identified the expression of SERPINE2, WISP2, GPNMB and ITIH5 in synoviums
and IPFPs of OA patients. All these genes were also detected in OA chondrocytes. Although
the expression of WISP2 and GPNMB in OA chondrocytes has been already described in
Fig 2. Determination of SERPINE2, WISP2 and ITIH5mRNA and protein expression by quantitative
real-time PCR and western blot. A. PCR results were shown in fold change, where black bars represent the
mRNA expression of SERPINE2 and ITIH5 in 10 different synovial tissues obtained from healthy donors.
Grey bars represent the mRNA expression of SERPINE2 and ITIH5 in 30 different synovial tissues obtained
from OA patients. B. PCR results were shown in fold change, where black bars represent the mRNA
expression of WISP2 in IPFP obtained from 10 healthy donors. Grey bars represent the mRNA expression of
WISP2 in IPFP obtained from 30 OA patients. Statistical analysis was performed using unpaired t-test. P
value * = p<0.05; ** = p<0.01 C vs OA.
doi:10.1371/journal.pone.0123601.g002
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previously published observations [16,17], our study demonstrates, for the first time, the ex-
pression of SERPINE2 and ITIH5 in human chondrocytes. Similarly, we also described for the
first time the expression of SERPINE2, WISP2, GPNMB and ITIH5 in the synovial tissues and
in the IPFPs of OA patients. Our data are partially in agreement with those observed by Tanaka
et al., which reported the expression of WISP2 by OA synovial tissues. However, these authors
only detected WISP2 expression in some of the analyzed synovial tissues [18], whereas, we
found WISP2 expression in all the synovial tissues tested so far.
In order to know whether these new adipokines could be modulated in OA, we compared
their expression in both healthy and OA tissues. As shown previously, we observed a differen-
tial expression of SERPINE2 and ITIH5 in the synovial tissues from OA patients and healthy
controls. During OA progression, synovial tissues may have histological and morphological
changes (synovitis) [19]. Although, the exact mechanism that leads to the synovitis in OA is
still unclear, pro-inflammatory adipokines, cytokines, chemokines and other molecular prod-
ucts of extracellular matrix degradation were proposed to be at play [19]. Noteworthy, it has
been reported that SERPINE2 was able to reduce plasminogen-induced degradation of muscle
extracellular matrix. It was also involved in the regulation of the expression of certain metallo-
proteinases in glioma cell lines [20,21]. In line with this, ITIH family proteins are known to
play a role in extracellular matrix stabilization of different cell types [22,23]. Collectively, these
evidences, together with our results, suggest that SERPINE2 and ITIH5 might be involved in
the histological alterations occurred in the synovial tissues during OA.
In the last years, the pathophysiological role of the IPFP has gained relevant consideration
as an active periarticular tissue able to secrete several soluble factors, which could contribute to
the pathogenesis of OA [4,9,13]. Actually, our group, very recently, demonstrated that IPFPs
from OA patients expressed higher levels of leptin and chemerin in comparison to healthy tis-
sues [9], suggesting that the IPFP may be a source of factors that impact joint tissues [9–11]. In
addition, microarray analysis of IPFPs from end-stage OA patients showed an increased ex-
pression of different adipokines such as leptin or adiponectin as compared to early-stage OA
patients tissues [24], reinforcing the concept of the existence of an altered adipokine secretion
pattern in OA joint tissues.
In the present study, we observed high expression of WISP2 in OA IPFPs. WISP2 is a direct
target gene of the WNT signaling pathway and it has been reported that different members of
the WNT family could participate in the progression of rheumatoid arthritis [25]. Actually,
WISP2 likely plays a role in inflammatory arthritis and cell differentiation [7,18]. So, the obser-
vation that differential expression of WISP2 observed in our study might have some repercus-
sion on OA progression would seen to make sense
In conclusion, we detected the expression of four new adipokines in cartilage, synovium and
IPFP, being some of them differentially expressed in OA tissues compared to healthy samples.
Our results suggest a potential involvement of these novel identified adipokines in osteoarthri-
tis. However, further studies are needed to determine the precise mechanism/s by which these
molecules may contribute to the onset and progression of osteoarthritis.
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